Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, has shown even greater weight loss in early trials (up to 24% body weight reduction)
In this article, Ill explore the origins of these concerns, examine why they may not apply to humans, and discuss what the data shows about thyroid cancer risks in people using GLP-1 medications
"In the short term, we have this temporary program, and then no clear path forward yet as to what will happen at the end of 2027," she said
In animal studies, thyroid C-cell tumours have been observed, though the clinical significance in humans remains under investigation
This approach can vary significantly from person to person, and it is essential to work closely with a clinician to determine the appropriate dosage
One connects HSA members with lower-cost healthcare options, starting with GLP-1 medications, and the other allows individuals to open and fund HSAs directly through a new digital enrollment tool